What is Oncology Ablation?
Oncology ablation portfolio: radiofrequency ablation (RFA) systems for hepatocellular carcinoma, microwave ablation (MWA) for liver and lung tumors, cryoablation for renal cell carcinoma, and percutaneous ablation electrodes. INVAMED interventional oncology devices.
Who manufactures Oncology Ablation devices?
INVAMED manufactures a complete range of oncology ablation devices at its ISO 13485 certified facility in Ankara, Turkey. All products carry CE marking under EU MDR 2017/745 and are exported to over 80 countries. INVAMED holds more than 100 international patents across its medical device portfolio.
Are Oncology Ablation devices FDA registered?
Yes. INVAMED oncology ablation devices are available in the United States through FDA-registered Standard Technology Solutions, Inc. at One World Trade Center, 285 Fulton Street, New York, NY 10007.
Frequently Asked Questions about Oncology Ablation
What is radiofrequency ablation (RFA) for tumors?
RFA uses high-frequency alternating current through needle electrodes to generate heat within tumors, causing coagulative necrosis. Primary indications include hepatocellular carcinoma, liver metastases, renal tumors, and lung nodules.
How does laser ablation treat urological tumors?
Laser trans-urethral ablation uses focused laser energy delivered through endoscopic instruments to vaporize or coagulate bladder tumors and treat benign prostatic hyperplasia (BPH) with minimal bleeding and faster recovery.
What is intracavitary hypothermia for bladder cancer?
Intracavitary hypothermia delivers controlled temperature therapy directly to the bladder to enhance the efficacy of intravesical chemotherapy agents. The combination of heat and chemotherapy improves drug penetration into tumor tissue.